ATXI Avenue Therapeutics
- 3.6100
- -0.1200-3.22%
Avenue Therapeutics News
Avenue Therapeutics: Received notice from NASDAQ that the company complies with all requirements set out in NASDAQ Listing Rule 5550 (B) (1)
Avenue Therapeutics: Received notice from NASDAQ that the company complies with all requirements set out in NASDAQ Listing Rule 5550 (B) (1)
Express News | Avenue Therapeutics: Received Notice From Nasdaq Notifying Co Is in Compliance With All Requirement Set Forth in Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Completes Last Patient Last Visit In Phase 1b/2a Clinical Trial Of AJ201 For Spinal And Bulbar Muscular Atrophy
Avenue Therapeutics Completes Last Patient Last Visit In Phase 1b/2a Clinical Trial Of AJ201 For Spinal And Bulbar Muscular Atrophy
Avenue Therapeutics (ATXI.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share were -15.40 dollars, previous value was -101.57 dollars, and expected value was -9.00 dollars.
Avenue Therapeutics (ATXI.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share were -15.40 dollars, previous value was -101.57 dollars, and expected value was -9.00 dollars.
Avenue Therapeutics | 10-Q: Quarterly report
Avenue Therapeutics Q1 EPS $(15.40) Misses $(9.00) Estimate
Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(15.40) per share which missed the analyst consensus estimate of $(9.00) by 71.11 percent. This is a 85.01 percent increase over losses
Avenue Therapeutics 1Q Loss/Shr $15.40 >ATXI
Avenue Therapeutics 1Q Loss/Shr $15.40 >ATXI
Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9M From Time To Time Through Agent
Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9M From Time To Time Through Agent
Avenue Capital Group Closes on Over $1 Billion in Commitments for European Strategy Targeting Asset-Backed Lending Opportunities
NEW YORK and LONDON, May 9, 2024 /PRNewswire/ -- Avenue Capital Group today announced the successful final closing of the Avenue Europe Special Situations Fund V (the "Avenue Europe Fund"). Together
Avenue Therapeutics Files to Sell 1.42M Shares
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
FLGC, BTOG and CAUD Among Mid-day Movers
Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
Avenue Therapeutics (NASDAQ:ATXI) shares are trading lower by 20.7% to $4.92 during Monday's session after the company announced the exercise of warrants for $4.4 million in gross proceeds.These warra
ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings Among Healthcare Movers
Avenue Therapeutics Announces Exercise of Warrants For $4.4M In Gross Proceeds
Avenue Therapeutics Announces Exercise of Warrants For $4.4M In Gross Proceeds
Avenue Therapeutics Shares Are Trading Lower. The Company Recently Announced a 1-for-75 Reverse Stock Split of Its Common Stock.
Avenue Therapeutics Shares Are Trading Lower. The Company Recently Announced a 1-for-75 Reverse Stock Split of Its Common Stock.
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Aon posted adjusted earnings of $5.66 per share, missing ma
Avenue Therapeutics To Carry Out 1-for-75 Reverse Stock Split On April 26th, 2024
April 25th - $Avenue Therapeutics(ATXI.US)$ is about to implement a 1-for-75 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 26th, 2024.$Avenue Therap
Crude Oil Moves Lower; B. Riley Financial Shares Jump
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday.The Dow traded down 0.18% to 38,434.99 while the NASDAQ fell 0.09% to 15,682.38. The S&P 500 als
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS
Analysis
Price Target
No Data
